Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CNNM1 | Q9NRU3 | Metal transporter CNNM1 (Ancient conserved domain-containing protein 1) (Cyclin-M1) | Predicted membrane proteinsTransporters | 4 | Metabolism mediation | 1 | 0.50 | |||
| CO8A | P07357 | Complement component C8 alpha chain (Complement component 8 subunit alpha) | 4 | Immune mediation | 1 | 0.50 | ||||
| COHA1 | Q9UMD9 | Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| CORIN | Q9Y5Q5 | Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment] | 1 | Metabolism mediation | 1 | 0.50 | ||||
| CRFR2 | Q13324 | Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2) | 7 | Anxiety disorderBinge eating disorderHeart failure | Clinical-translation mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| CSMD3 | Q7Z407 | CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) | Predicted membrane proteins | 2 | Other mediation | 1 | 0.50 | |||
| CT141 | Q9NUB4 | Uncharacterized protein C20orf141 | 1 | Other mediation | 1 | 0.50 | ||||
| CTR2 | P52569 | Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2) | 14 | Fusion and delivery mediation | 1 | 0.50 | ||||
| CTR4 | O43246 | Cationic amino acid transporter 4 (CAT-4) (CAT4) (Solute carrier family 7 member 4) | Predicted membrane proteinsTransporters | 13 | Fusion and delivery mediation | 1 | 0.50 | |||
| CX3C1 | P49238 | CX3C chemokine receptor 1 (C-X3-C CKR-1) (CX3CR1) (Beta chemokine receptor-like 1) (CMK-BRL-1) (CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28) | Disease related genesG-protein coupled receptorsHuman disease related genes | 7 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| CXB7 | Q6PEY0 | Gap junction beta-7 protein (Connexin-25) (Cx25) | 4 | Fusion and delivery mediation | 1 | 0.50 | ||||
| CXCR2 | P25025 | C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD antigen CD182) | Cancer-related genesCD markersDisease related genes | 7 | AsthmaChronic obstructive pulmonary diseaseCystic fibrosis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| CXG1 | P36383 | Gap junction gamma-1 protein (Connexin-45) (Cx45) (Gap junction alpha-7 protein) | 4 | Fusion and delivery mediation | 1 | 0.50 | ||||
| CXG2 | Q5T442 | Gap junction gamma-2 protein (Connexin-46.6) (Cx46.6) (Connexin-47) (Cx47) (Gap junction alpha-12 protein) | 4 | Fusion and delivery mediation | 1 | 0.50 | ||||
| CYBR1 | Q53TN4 | Plasma membrane ascorbate-dependent reductase CYBRD1 (EC 7.2.1.3) (Cytochrome b reductase 1) (Duodenal cytochrome b) (Ferric-chelate reductase 3) | EnzymesMetabolic proteinsPredicted membrane proteins | 6 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| DAG1 | Q14118 | Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)] | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| DCBD2 | Q96PD2 | Discoidin, CUB and LCCL domain-containing protein 2 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1) (Endothelial and smooth muscle cell-derived neuropilin-like protein) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.50 | |||
| DDR1 | Q08345 | Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a) | CD markersEnzymesPredicted intracellular proteins | 1 | Adhesion and uptake mediationClinical-translation mediationReceptor-signaling mediation | 1 | 0.50 | |||
| DDR2 | Q16832 | Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| DGLB | Q8NCG7 | Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta) | 4 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | ||||
| DLL1 | O00548 | Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1) | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||||
| DRD1 | P21728 | D(1A) dopamine receptor (Dopamine D1 receptor) | 7 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| DSEL | Q8IZU8 | Dermatan-sulfate epimerase-like protein (EC 5.1.-.-) | 2 | Metabolism mediation | 1 | 0.50 | ||||
| EGFR | P00533 | Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) | Cancer-related genesDisease related genesEnzymes | 1 | Angina pectorisBrain cancerBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| EGLN | P17813 | Endoglin (CD antigen CD105) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | AngiosarcomaBrain cancerBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 |